$0.780100
-0.05-6.01%
Last update: 9:17 AM
15 minutes delayed
Comments
Loading...
PainReform (NASDAQ:PRFX) Stock Quotes, Forecast and News Summary
PainReform Stock (NASDAQ: PRFX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 65.82K / 360.35K |
| Day Range | - - - |
| 52 Wk Range | 0.72 - 23.88 |
| Market Cap | $913.53K |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 28 |
| Short Interest | 1.53% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulat...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy PainReform (PRFX) stock?
You can purchase shares of PainReform (NASDAQ:PRFX) through any online brokerage.
Who are PainReform (PRFX) competitors?
There are no as such competitors for PainReform.
What is the forecast, or price target, for PainReform (PRFX) stock?
PainReform has a consensus price target of $2.00.
What is the current price for PainReform (PRFX)?
The stock price for PainReform (NASDAQ: PRFX) is $0.7801 last updated September 19, 2024 at 9:17 AM EDT.
Does PainReform (PRFX) pay a dividend?
There are no upcoming dividends for PainReform.
When is PainReform (NASDAQ:PRFX) reporting earnings?
PainReform’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is PainReform (PRFX) going to split?
There is no upcoming split for PainReform.
What sector and industry does PainReform (PRFX) operate in?
PainReform is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.